Sunitix Capsule 37.5 mg contains Sunitinib, an oral targeted anticancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. It is used in the treatment of certain advanced or metastatic cancers. Sunitinib works by blocking specific enzymes involved in cancer cell growth and by preventing the formation of new blood vessels that supply tumors.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Sunitinib 37.5 mg

Mechanism of Action

Sunitinib inhibits multiple receptor tyrosine kinases involved in tumor progression, including:

• Vascular endothelial growth factor receptors (VEGFR)
• Platelet-derived growth factor receptors (PDGFR)
• KIT and related signaling pathways

By blocking these pathways, it reduces tumor cell proliferation and angiogenesis, helping to slow disease progression and tumor growth.

Indications

Sunitix Capsule 37.5 mg is indicated for the treatment of:

• Metastatic renal cell carcinoma (kidney cancer)
• Gastrointestinal stromal tumors (GIST) after resistance or intolerance to imatinib
• Pancreatic neuroendocrine tumors (pNET), progressive and unresectable cases

Dosage and Administration

• Dosage must be prescribed and monitored by an oncologist.
• Commonly given as a once-daily oral dose, often in treatment cycles.
• Can be taken with or without food.
• Swallow whole with water; do not open or crush the capsule.
• Regular monitoring is required throughout therapy.

Benefits

• Targets multiple pathways involved in cancer growth
• Helps slow progression of advanced malignancies
• Oral therapy improves patient convenience
• Useful in certain treatment-resistant cancers
• May improve progression-free survival in selected patients

Side Effects

Common side effects may include:

• Fatigue
• Nausea or vomiting
• Diarrhea
• Decreased appetite
• Skin discoloration or hand-foot syndrome
• High blood pressure

Serious side effects may include heart problems, liver toxicity, bleeding, thyroid dysfunction, or severe infections. Immediate medical attention is required if severe symptoms occur.

Precautions and Warnings

• Must be used only under oncology supervision.
• Regular monitoring of blood pressure, thyroid function, liver function, and blood counts is essential.
• Not recommended during pregnancy due to potential fetal harm.
• Effective contraception should be used during and after treatment as advised.
• Use caution in patients with cardiovascular disease or bleeding risk.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Sunitix Capsule may interact with:

• Strong CYP3A4 inhibitors or inducers
• Anticoagulants (increased bleeding risk)
• Certain antifungal, antibiotic, or antiviral medications
• Other anticancer drugs

Always inform your healthcare provider about all current medications.

Storage

• Store below 30°C in a cool, dry place
• Protect from light and moisture
• Keep out of reach of children.